{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:10:35Z","timestamp":1791429035954,"version":"4.3.3"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T00:00:00Z","timestamp":1628726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["ZIA MH000889"],"award-info":[{"award-number":["ZIA MH000889"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.nbd.2021.105485","type":"journal-article","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T11:27:43Z","timestamp":1629113263000},"page":"105485","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Effects of chronic inhibition of phosphodiesterase-4D on behavior and regional rates of cerebral protein synthesis in a mouse model of fragile X syndrome"],"prefix":"10.1016","volume":"159","author":[{"given":"Michael","family":"Rosenheck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Sheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel Michelle","family":"Sar\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Gurney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn Beebe","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2021.105485_bb0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/(SICI)1097-4547(19980101)51:1<41::AID-JNR4>3.0.CO;2-L","article-title":"Overexpression of fragile X gene (FMR-1) transcripts increases cAMP production in neural cells","volume":"51","author":"Berry-Kravis","year":"1998","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2021.105485_bb0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ana.410310105","article-title":"Cyclic AMP metabolism in fragile X syndrome","volume":"31","author":"Berry-Kravis","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2021.105485_bb0015","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ajmg.1320450120","article-title":"Demonstration of abnormal cyclic AMP production in platelets from patients with fragile X syndrome","volume":"45","author":"Berry-Kravis","year":"1993","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.nbd.2021.105485_bb0020","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1203\/00006450-199511000-00002","article-title":"Reduced cyclic AMP production in fragile X syndrome: cytogenetic and molecular correlations","volume":"38","author":"Berry-Kravis","year":"1995","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.nbd.2021.105485_bb0025","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1523\/JNEUROSCI.1356-12.2015","article-title":"PDE-4 inhibition rescues aberrant synaptic plasticity in Drosophila and mouse models of fragile X syndrome","volume":"35","author":"Choi","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2021.105485_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2016.00136","article-title":"Multiple drug treatments that increase cAMP signaling restore long-term memory and aberrant signaling in fragile X syndrome models","volume":"10","author":"Choi","year":"2016","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.nbd.2021.105485_bb0040","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/jnc.14874","article-title":"Effects of the presence and absence of amino acids on translation, signaling, and long-term depression in hippocampal slices from Fmr1 knockout mice","volume":"151","author":"Cooke","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2021.105485_bb0045","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1073\/pnas.86.10.3604","article-title":"Cloning and characterization of mammalian homologs of the Drosophila dunce+ gene","volume":"86","author":"Davis","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2021.105485_bb0055","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1101\/lm.830008","article-title":"Activation of exchange protein activated by cyclic-AMP enhances long-lasting synaptic potentiation in the hippocampus","volume":"15","author":"Gelinas","year":"2008","journal-title":"Learn. Mem."},{"key":"10.1016\/j.nbd.2021.105485_bb0060","doi-asserted-by":"crossref","first-page":"14653","DOI":"10.1038\/s41598-017-15028-x","article-title":"Multiple behavior phenotypes of the fragile-X syndrome mouse model respond to chronic inhibition of phosphodiesterase-4D (PDE4D)","volume":"7","author":"Gurney","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2021.105485_bb0065","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1021\/acs.jmedchem.9b00193","article-title":"Design and synthesis of selective phosphodiesterase 4D (PDE4D) allosteric inhibitors for the treatment of fragile X syndrome and other brain disorders","volume":"62","author":"Gurney","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.nbd.2021.105485_bb0070","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nn1381","article-title":"Cyclic AMP controls BDNF-induced TrkB phosphorylation and dendritic spine formation in mature hippocampal neurons","volume":"8","author":"Ji","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2021.105485_bb0075","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1126\/science.282.5397.2275","article-title":"A family of cAMP-binding proteins that directly activate Rap1","volume":"282","author":"Kawasaki","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.nbd.2021.105485_bb0080","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.cell.2008.10.017","article-title":"The autistic neuron: troubled translation?","volume":"135","author":"Kelleher","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2021.105485_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000931","article-title":"The cyclic AMP cascade is altered in the fragile X nervous system","volume":"2","author":"Kelley","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2021.105485_bb0090","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.neubiorev.2008.06.005","article-title":"The cyclic AMP phenotype of fragile X and autism","volume":"32","author":"Kelley","year":"2008","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.nbd.2021.105485_bb0100","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neulet.2009.02.066","article-title":"Dissociation of social and nonsocial anxiety in a mouse model of fragile X syndrome","volume":"454","author":"Liu","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2021.105485_bb0105","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1017\/S1461145710000520","article-title":"Lithium ameliorates phenotypic deficits in a mouse model of fragile X syndrome","volume":"14","author":"Liu","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.nbd.2021.105485_bb0110","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.nbd.2011.12.037","article-title":"Lithium reverses increased rates of cerebral protein synthesis in a mouse model of fragile X syndrome","volume":"45","author":"Liu","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2021.105485_bb0115","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1152\/physrev.00014.2003","article-title":"Long-term potentiation and memory","volume":"84","author":"Lynch","year":"2004","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.nbd.2021.105485_bb0130","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1601-183X.2004.00071.x","article-title":"Automated apparatus for quantitation of social approach behaviors in mice","volume":"3","author":"Nadler","year":"2004","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.nbd.2021.105485_bb0135","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1523\/JNEUROSCI.22-09-03673.2002","article-title":"Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding protein","volume":"22","author":"Nakagawa","year":"2002","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.nbd.2021.105485_bb0140","doi-asserted-by":"crossref","first-page":"R249","DOI":"10.1093\/hmg\/ddg298","article-title":"A fragile balance: FMR1 expression levels","volume":"12","author":"Oostra","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2021.105485_bb0145","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0092-8674(89)90099-8","article-title":"Neural induction is mediated by cross-talk between the protein kinase C and cyclic AMP pathways","volume":"58","author":"Otte","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2021.105485_bb0150","doi-asserted-by":"crossref","first-page":"15758","DOI":"10.1073\/pnas.242377399","article-title":"Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation","volume":"99","author":"Qin","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2021.105485_bb0155","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1523\/JNEUROSCI.0093-05.2005","article-title":"Postadolescent changes in regional cerebral protein synthesis: an in vivo study in the FMR1 null mouse","volume":"25","author":"Qin","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2021.105485_bb0160","first-page":"18","article-title":"R-baclofen reverses a social behavior deficit and elevated protein synthesis in a mouse model of fragile X syndrome","author":"Qin","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.nbd.2021.105485_bb0170","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0035-16.2016","article-title":"Behavioral phenotype of Fmr1 knockout mice during active phase in an altered light dark cycle","author":"Sare","year":"2016","journal-title":"eNeuro"},{"key":"10.1016\/j.nbd.2021.105485_bb0175","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3389\/fnmol.2017.00280","article-title":"Deficient sleep in mouse models of fragile X syndrome","volume":"10","author":"Sare","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2021.105485_bb0180","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3389\/fnmol.2017.00452","article-title":"Negative effects of chronic rapamycin treatment on behavior in a mouse model of fragile X syndrome","volume":"10","author":"Sare","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2021.105485_bb0185","first-page":"e58503","article-title":"A quantitative autoradiographic L-[1-14C]leucine method for determination of regional rates of cerebral protein synthesis in vivo","volume":"148","author":"Sare","year":"2018","journal-title":"J. Visual. Exp."},{"key":"10.1016\/j.nbd.2021.105485_bb0190","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0379-19.2020","article-title":"Sex-selective effects on behavior in a mouse model of tuberous sclerosis complex","volume":"7","author":"Sare","year":"2020","journal-title":"eNeuro"},{"key":"10.1016\/j.nbd.2021.105485_bb0195","doi-asserted-by":"crossref","first-page":"11014","DOI":"10.1073\/pnas.97.20.11014","article-title":"Cerebral protein synthesis in a genetic mouse model of phenylketonuria","volume":"97","author":"Smith","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2021.105485_bb0200","doi-asserted-by":"crossref","first-page":"9341","DOI":"10.1073\/pnas.85.23.9341","article-title":"Measurement of local cerebral protein synthesis in vivo: influence of recycling of amino acids derived from protein degradation","volume":"85","author":"Smith","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2021.105485_bb0205","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/bjp.2008.307","article-title":"PDE4 inhibitors: current status","volume":"155","author":"Spina","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2021.105485_bb0210","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/jnr.10754","article-title":"Dual role of cyclic AMP-dependent protein kinase in neuritogenesis and synaptogenesis during neuronal differentiation","volume":"74","author":"Tojima","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2021.105485_bb0215","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2165\/00023210-200418110-00001","article-title":"Neuropsychiatric symptoms of fragile X syndrome: pathophysiology and pharmacotherapy","volume":"18","author":"Tsiouris","year":"2004","journal-title":"CNS Drugs"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996121002345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996121002345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:27:51Z","timestamp":1760851671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996121002345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":37,"alternative-id":["S0969996121002345"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2021.105485","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of chronic inhibition of phosphodiesterase-4D on behavior and regional rates of cerebral protein synthesis in a mouse model of fragile X syndrome","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2021.105485","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105485"}}